Boehringer Ingelheim
Boehringer-Backed Health Program Enrolls 10,000 Kenyans in Chronic Disease Care
A community health program backed by Boehringer Ingelheim has enrolled more than 10,000 patients in long-term treatment for hypertension and Type 2 diabetes...
OORO GEORGE2 Mins read
German Pharma Giant Announces Results of Its Kenyan Healthcare Programs
Kuza Afya programme screens over 70,000 people and enrolled over 5000 patients for diabetes and hypertension care
BT Correspondent3 Mins read
Kenyan Farmers to Benefit From Digital Farm Extension Services
German corporation launches 'LastMile' initiative to address barriers in animal healthcare sector in Sub-Saharan Africa
BT Correspondent2 Mins read
Ksh 63.9 Million Relief Fund to Benefit SMEs in Kenya
The fund will help social enterprises sustain a longer period of low economic activity
BT Correspondent3 Mins read
German pharma taps African innovators to boost rural health
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, has called on innovators in Africa to adopt viable business models for their enterprises...
BT Correspondent1 Mins read
Boost for Kenya’s healthcare provision as doctors set to be trained
Kenyan patients set to benefit from partnership between German pharmaceutical giant Boehringer Ingelheim and AMPATH Consortium
BT Correspondent3 Mins read
Boehringer Ingelheim launches its global Angels initiative in Kenya
To address the burden of stroke worldwide, the company’s Angels initiative aims to improve standards for stroke care across the world
BT Correspondent3 Mins read
New drug for management of type 2 diabetes introduced in Kenya
The medical solution works to improve glycemic control in adults with the condition, along with diet and exercise
BT Correspondent3 Mins read
Pharmaceutical firm backs social investments in healthcare
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and Ashoka, the world’s largest network of social entrepreneurs, have held a co-creation workshop...
BT Correspondent1 Mins read
